Hacking goes squishy
By The Economist,
The Economist
| 09. 03. 2009
MANY of the world’s great innovators started out as hackers—people who like to tinker with technology—and some of the largest technology companies started in garages. Thomas Edison built General Electric on the foundation of an improved way to transmit messages down telegraph wires, which he cooked up himself. Hewlett-Packard was founded in a garage in California (now a national landmark), as was Google, many years later. And, in addition to computer hardware and software, garage hackers and home-build enthusiasts are now merrily cooking up electric cars, drone aircraft and rockets. But what about biology? Might biohacking—tinkering with the DNA of existing organisms to create new ones—lead to innovations of a biological nature?
The potential is certainly there. The cost of sequencing DNA has fallen from about $1 per base pair in the mid-1990s to a tenth of a cent today, and the cost of synthesising the molecule has also fallen. Rob Carlson, the founder of a firm called Biodesic, started tracking the price of synthesis a decade ago. He found a remarkably steady decline, from over $10 per base pair...
Related Articles
By Hannah Devlin, The Guardian | 05.14.2024
Photo by Kind and Curious from Unsplash
When Great Ormond Street hospital (Gosh) published the results of its gene therapy trial for “bubble baby” syndrome it was hailed as a medical breakthrough. The treatment had a more than 95% success...
By Victoria Bisset and Adela Suliman, The Washington Post | 05.09.2024
Photo by CDC from Unsplash
A baby girl born with profound genetic deafness can now hear unaided after receiving a “groundbreaking” gene therapy trial, Britain’s National Health Service said Thursday.
Opal Sandy, an 18-month-old from Oxfordshire, England, is the first...
By Carrie Arnold, Nature Biotechnology | 04.17.2024
Tome Biosciences came out of stealth mode on 12 December with a haul of over $200 million to develop the company’s gene editing platform. Tome’s first order of business was to snap up Replace Therapeutics to expand its toolkit to...
By Charlotte Hu, Vox | 05.06.2024
Medicine has entered a new era in which scientists have the tools to change human genetics directly, creating the potential to treat or even permanently cure diseases by editing a few strands of troublesome DNA. And CRISPR, the gene-editing...